Yutaka Tsutsumi

Dr. Yutaka Tsutsumi

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in ACTA HISTOCHEMICA ET CYTOCHEMICA
Verified
Journal Article
Open access
PDF file
YTYutaka Tsutsumi
Yutaka Tsutsumi
In the diagnostic pathology practice, specimens for electron microscopy (EM) are not necessarily handled and fixed under the ideal condition. In the present article, the author describes ultrastructural study using formalin-fixed and/or paraffin-embedded material. The fine morphologic preservation is often acceptable, particularly when small cubes are dug out of paraffin blocks. Particulate structures such as neuroendocrine granules and microbes are consistently observed even using paraffin sections. Paraffin sections signalized with silver particles in Grimelius and Grocott stains or diaminobenzidine products in immunostaining and in situ hybridization are applicable to EM evaluation by using a pre-embedding sequence. The practical merit includes the targeted approach: highly accurate sampling from focal lesions can be achieved for EM analysis, after observing hematoxylin and eosin-stained or specific-signalized paraffin-sections. This allows us pathologists a convenient and practical way for identifying focally infected pathogens, as well as a retrospective ultrastructural analysis of rare lesions long kept as a form of paraffin blocks.

15 June 2021 in Cells
Verified
Journal Article
Open access
PDF file
YTYutaka Tsutsumi
Yutaka Tsutsumi
Chromogenic immunohistochemistry (immunostaining using an enzyme-labeled probe) is an essential histochemical technique for analyzing pathogenesis and making a histopathological diagnosis in routine pathology services. In neoplastic lesions, immunohistochemistry allows the study of specific clinical and biological features such as histogenesis, behavioral characteristics, therapeutic targets, and prognostic biomarkers. The needs for appropriate and reproducible methods of immunostaining are prompted by technical development and refinement, commercial availability of a variety of antibodies, advanced applicability of immunohistochemical markers, accelerated analysis of clinicopathological correlations, progress in molecular targeted therapy, and the expectation of advanced histopathological diagnosis. However, immunostaining does have various pitfalls and caveats. Pathologists should learn from previous mistakes and failures and from results indicating false positivity and false negativity. The present review article describes various devices, technical hints, and trouble-shooting guides to keep in mind when performing immunostaining.

4 June 2018 in Pathology International
Verified
Journal Article
Closed access
PDF file
MFMari Fujii
Mari Fujii
YMYasuyoshi Mizutani
Yasuyoshi Mizutani
TSTakahiko Sakuma
Takahiko Sakuma
KTKouichiro Tagami
Kouichiro Tagami
KOKiichiro Okamoto
Kiichiro Okamoto
YTYutaka Tsutsumi
Yutaka Tsutsumi

1 March 2006 in Cardiology
Verified
Journal Article
Closed access
PDF file
HKHiroe Kanamori
Hiroe Kanamori
YTYutaka Tsutsumi
Yutaka Tsutsumi
AMAkio Mori
Akio Mori
TKTakahito Kawamura
Takahito Kawamura
SOShinji Obara
Shinji Obara
NMNobuo Masauzi
Nobuo Masauzi
We report 3 cases of reduced cardiac function with complications in non-Hodgkin’s lymphoma patients who were treated with rituximab. Patients experienced reduced cardiac functions after the administration of rituximab; there was no evidence of any preceding infusion reactions. Reticulin fiber was observed diffusely in cardiac muscles. Transforming growth factor-β levels were elevated after the administration of rituximab. We believe that continuous elevation of transforming growth factor-β may promote the growth of reticulin fiber in cardiac muscles. Reduction in cardiac functions is a severe complication that must be considered when rituximab is administered.

6 February 2020 in Pathology International
Verified
Journal Article
Open access
PDF file
MTMitsuhiro Tachibana
Mitsuhiro Tachibana
MSMasao Saito
Masao Saito
JKJun Kobayashi
Jun Kobayashi
TITadahiro Isono
Tadahiro Isono
YYYasushi Yatabe
Yasushi Yatabe
YTYutaka Tsutsumi
Yutaka Tsutsumi
Bronchiolar adenoma (BA) of the lung is a rare benign neoplasm. Because of a chest abnormal shadow indicated by health checkup, a 77‐year‐old female nonsmoker underwent computed tomography, revealing an 8 mm ground glass nodule in the peripheral field of the right lower lobe. Wedge resection of the nodule was performed, with a frozen diagnosis of primary lung adenocarcinoma. The localized, 8 × 4 × 3 mm‐sized, jelly‐like mass microscopically revealed a lepidic‐growing lesion composed of ciliated columnar cells, mucous cells and basal cells surrounded by mucin pool. Neither nuclear atypia nor mitotic activity was noted. Immunohistochemically, the ciliated, mucous and basal cells were positive for TTF‐1 and p16INK4a. Mucous cells were positive for napsin A and focally expressed MUC5AC. MUC6 was negative. Basal cells were positive for CK5/6, p40, p63 and podoplanin. Human papillomavirus genome was undetectable by in situ hybridization. Ultrastructurally, the bronchiolar epithelial tubules consisted of two layers, the inner nonciliated microvillous cells and the outer basal‐like cells, and some of the inner cells were filled with mucin granules in cytoplasm. Molecular analysis of the tumor failed to show driver mutations. The final diagnosis was distal‐type BA. The postoperative course was uneventful for 6 months.

27 February 2019 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
RIRyosuke Ishida
Ryosuke Ishida
KUKazunori Ueda
Kazunori Ueda
TKTadashi Kitano
Tadashi Kitano
TYTomohiko Yamamoto
Tomohiko Yamamoto
YMYasuyoshi Mizutani
Yasuyoshi Mizutani
YYYuji Yamamori
Yuji Yamamori
Bacillus cereus is a gram-positive rod bacterium that is responsible for food poisoning. It is naturally widely distributed, and thus often contaminates cultures. Although it is rarely considered responsible, it can cause serious infections under certain conditions. However, lethal infections, especially in immunocompetent patients, are rare. A healthy 60-year-old man developed community-acquired B. cereus pneumonia and alveolar hemorrhage unveiled by abrupt chest pain and hemoptysis with no other advance symptoms. B. cereus induced silent alveolar destruction without any local or systemic inflammatory response. Although the lesion resembled lung anthrax, there was no evidence of Bacillus anthracis toxin. Some isolates of B. cereus can cause anthrax-like fulminant necrotizing pneumonia in immunocompetent patients. If this type of B. cereus were used as a means of bioterrorism, it may be quite difficult to recognize as bioterrorism. We should keep B. cereus in mind as a potential pathogen of fulminant human infectious disease.